RE: Lock down pressure1 Nov 2020 08:15
Southampton based biotech firm is ready for its final stage clinical trials after testing the SNG001 in over 900 people across 20 different countries around the world. Phase 3 of the clinical studies are set to take place in November, and with the help of clinical research organization, Parexel, should have the trials wrapped up within a year.
Looking good over the next few weeks plenty of people about with covid , panic is setting in .
SNG brake through the share price is set to rocket.
The lowest sp I paid was .67p and the highest 2.40 when the sp was moving fast, with vulnerability of the stocks market with covid brexit and global warming now wonder we have all gone mad lol
Nice Christmas present for the sick and stock holders.